SUPPLY OF
OUR PRODUCTS
From time to time we may experience shortages of some products and may divest or discontinue others.
For healthcare professionals who require more information about shortages, please contact:
MSD UK customer services on 01992 452094 (during public holidays please contact our UK switchboard on 01992 467272).
Please click here to download an emergency patient supply order form (for use by UK healthcare professionals only).
If you are a patient seeking information on how shortages may affect your treatment, we recommend that you consult your doctor.
For more information about our products, please call our medical information line via our switchboard on 01992 467272.
Supply Status
| Product Description | Supply Status | Estimated Resupply Date |
|---|---|---|
|
OOS | Early October 2018 |
|
OOS | November 2018 |
|
OOS | November 2018 |
|
OOS | November 2018 |
|
OOS | November 2018 |
|
OOS | Quarter 1 2019 |
|
OOS | Early October 2018 |
Notifications
KEYTRUDA▼ (pembrolizumab) – 50 mg vial supply arrangements
From December 2018, pembrolizumab will be supplied by MSD in the UK exclusively in the form of 100 mg vial (25 mg/mL concentrate for solution for infusion) and availability of the 50 mg vial as lyophilised powder (50 mg powder for concentrate for solution for infusion) will begin to cease. At that time, remaining stocks of the 50 mg vial of pembrolizumab powder for concentrate for solution for infusion may continue to be used until the stock is finished.
Discontinuations
- ARCOXIA® 90 mg Film-coated Tablets 5 Pack
- CRIXIVAN 400 mg
- ESMERON 10mg/ml Solution for Injection 10ml vial
- MODURET-25 25/2.5 mg Tablets
- NORCURON® (vecuronium bromide)
- PREGNYL 1500.I.U powder for solution for injection
- PREGNYL 5000.I.U powder for solution for injection
- PUREGON 50IU/0.5ml solution for injection
- PUREGON 100IU/0.5ml solution for injection
Job code: CORP-1245798-0011Date of preparation: September 2018